The expression of LMP2 protein was found to be attenuated in 85% of specimens of uterine leiomyosarcomas, and LMP2 immunostaining was shown to be useful for differential diagnosis of uterine leiomyomas and leiomyosarcomas17, 18. The gene discussed is PSMB9; the disease is uterine corpus leiomyoma.